Danaher Corporation (NYSE:DHR) Receives $246.35 Consensus PT from Analysts

Key Points

• Danaher Corporation (NYSE:DHR) has been assigned an average rating of "Moderate Buy" by brokerages, with 17 out of 20 analysts recommending purchase.
• The stock has a market capitalization of $142.47 billion and reported earnings of $1.80 per share, exceeding expectations for the latest quarter.
• Three brokerages recently upgraded Danaher's rating, with Scotiabank giving a target price of $275.00 per share.

Danaher Corporation (NYSE:DHR - Get Free Report) has earned a consensus rating of "Moderate Buy" from the twenty analysts that are currently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $246.3478.

Several research analysts have weighed in on DHR shares. Robert W. Baird increased their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research note on Friday, July 18th. Wall Street Zen upgraded Danaher from a "hold" rating to a "buy" rating in a report on Friday, June 27th. Barclays reissued an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Evercore ISI lowered their price objective on shares of Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research note on Tuesday, July 8th. Finally, UBS Group lowered their price objective on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research note on Wednesday, July 23rd.

Danaher Trading Down 2.6%

Shares of DHR traded down $5.13 during mid-day trading on Friday, reaching $193.50. The stock had a trading volume of 1,664,411 shares, compared to its average volume of 4,127,485. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market cap of $138.55 billion, a price-to-earnings ratio of 41.18, a P/E/G ratio of 2.79 and a beta of 0.75. The business's fifty day moving average is $201.95 and its 200 day moving average is $199.23. Danaher has a 52-week low of $171.00 and a 52-week high of $279.90.

Danaher (NYSE:DHR - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. Danaher's revenue was up 3.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts predict that Danaher will post 7.63 EPS for the current fiscal year.

Insider Activity at Danaher

In related news, Director Teri List sold 2,778 shares of the firm's stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director owned 20,751 shares of the company's stock, valued at $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 11.20% of the company's stock.

Institutional Trading of Danaher

Hedge funds have recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in shares of Danaher during the 2nd quarter worth about $1,979,503,000. Nuveen LLC acquired a new stake in Danaher during the first quarter worth approximately $833,941,000. Viking Global Investors LP raised its holdings in Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate's stock worth $574,351,000 after purchasing an additional 2,455,994 shares in the last quarter. GAMMA Investing LLC raised its holdings in Danaher by 24,958.2% during the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock worth $383,524,000 after purchasing an additional 1,863,381 shares in the last quarter. Finally, Generation Investment Management LLP increased its holdings in shares of Danaher by 56.2% in the 2nd quarter. Generation Investment Management LLP now owns 4,965,646 shares of the conglomerate's stock valued at $980,914,000 after acquiring an additional 1,787,522 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.